The Oceania Times

Top Menu

  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

Main Menu

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

logo

The Oceania Times

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • Asian shares fall as investors brace for inflation report

  • A-Mark Precious Metals (NASDAQ:AMRK) vs. Maison Luxe (OTCMKTS:MASN) Head-To-Head Comparison

  • Stock Market LIVE: Indices flat; Nifty below 17,500; IT, Media drag

  • The big change coming to Australian inflation after Reserve Bank governor Philip Lowe laughed at

  • South Korean won, Philippines peso lead losses among subdued Asian currencies

Stock Shares
Home›Stock Shares›Ron Bentsur Purchases 1,000 Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock

Ron Bentsur Purchases 1,000 Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT) Stock

By Megan
May 23, 2022
17
0
Share:

Nuvectis Pharma logoNuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) CEO Ron Bentsur acquired 1,000 shares of the stock in a transaction dated Friday, May 20th. The shares were bought at an average cost of $16.28 per share, with a total value of $16,280.00. Following the transaction, the chief executive officer now directly owns 2,962,614 shares of the company’s stock, valued at $48,231,355.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Ron Bentsur also recently made the following trade(s):

  • On Wednesday, May 18th, Ron Bentsur acquired 1,700 shares of Nuvectis Pharma stock. The shares were bought at an average cost of $19.36 per share, with a total value of $32,912.00.
  • On Monday, May 16th, Ron Bentsur bought 1,000 shares of Nuvectis Pharma stock. The shares were acquired at an average price of $19.32 per share, with a total value of $19,320.00.
  • On Thursday, May 12th, Ron Bentsur bought 12,245 shares of Nuvectis Pharma stock. The shares were acquired at an average price of $16.99 per share, with a total value of $208,042.55.
  • On Monday, March 28th, Ron Bentsur bought 4,000 shares of Nuvectis Pharma stock. The shares were acquired at an average price of $7.05 per share, with a total value of $28,200.00.
  • On Thursday, March 17th, Ron Bentsur bought 7,000 shares of Nuvectis Pharma stock. The shares were acquired at an average price of $7.63 per share, with a total value of $53,410.00.
(Ad)

This is a stock chart pattern that signals a bullish market trend… Every investor should know this stock chart pattern.

There are two more on the next page.

Click here to see this pattern now

Shares of NVCT stock opened at $15.50 on Monday. The company has a fifty day moving average price of $10.77. Nuvectis Pharma, Inc. has a one year low of $3.08 and a one year high of $20.92.

Hedge funds have recently made changes to their positions in the business. Virtu Financial LLC bought a new position in shares of Nuvectis Pharma in the first quarter valued at about $84,000. BlackRock Inc. bought a new position in Nuvectis Pharma during the first quarter worth about $59,000. Finally, Ronit Capital LLP bought a new position in Nuvectis Pharma during the first quarter worth about $4,076,000.

NVCT has been the subject of several recent research reports. Roth Capital restated a “buy” rating on shares of Nuvectis Pharma in a report on Sunday, April 17th. HC Wainwright increased their price target on shares of Nuvectis Pharma from $14.00 to $21.00 in a research note on Tuesday, May 10th.

Nuvectis Pharma Company Profile (Get Rating)

Nuvectis Pharma, Inc, a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases.

See Also

Insider Buying and Selling by Quarter for Nuvectis Pharma (NASDAQ:NVCT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Nuvectis Pharma right now?

Before you consider Nuvectis Pharma, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Nuvectis Pharma wasn’t on the list.

While Nuvectis Pharma currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 

Source link

Tagsinsider buying and sellinginstant alertsNASDAQ:NVCTNuvectis Pharma
Previous Article

Broker’s call: JK Tyre (Buy)

Next Article

G&W Electric Company Announces $3.6 million Strategic ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Megan

Related articles More from author

  • Stock Shares

    Johnson Matthey PLC (LON:JMAT) Insider Stephen Oxley Acquires 18 Shares

    July 25, 2022
    By Megan
  • Investment

    New Residential Investment Corp. (NYSE:NRZ) Given Average Recommendation of “Buy” by Analysts

    June 17, 2022
    By Megan
  • Stock Shares

    Emma Walmsley Sells 148,525 Shares of GSK plc (LON:GSK) Stock

    July 30, 2022
    By Megan
  • Stock Shares

    Insider Buying: Rotork plc (LON:ROR) Insider Buys 10,000 Shares of Stock

    May 30, 2022
    By Megan
  • Brokers

    Brokers Offer Predictions for WNS (Holdings) Limited’s Q1 2023 Earnings (NYSE:WNS)

    July 18, 2022
    By Megan
  • Investment

    Bridge Investment Group Holdings Inc. (NYSE:BRDG) Receives Consensus Rating of “Buy” from Analysts

    June 4, 2022
    By Megan

Leave a reply Cancel reply

You may interested

  • Brokers

    CICC investment banking head to take helm at broker Galaxy – sources

  • Brokers

    How can brokers get ahead in a tight market?

  • Australian Economy

    Australia Market falls on rate hike, economy fears

  • LATEST REVIEWS

  • TOP REVIEWS

Timeline

  • August 10, 2022

    Asian shares fall as investors brace for inflation report

  • August 10, 2022

    A-Mark Precious Metals (NASDAQ:AMRK) vs. Maison Luxe (OTCMKTS:MASN) Head-To-Head Comparison

  • August 10, 2022

    Stock Market LIVE: Indices flat; Nifty below 17,500; IT, Media drag

  • August 10, 2022

    The big change coming to Australian inflation after Reserve Bank governor Philip Lowe laughed at

  • August 10, 2022

    South Korean won, Philippines peso lead losses among subdued Asian currencies

Best Reviews

Latest News

Stock Shares

Asian shares fall as investors brace for inflation report

People walk past a screen displaying the Hang Seng stock index outside Hong Kong Exchanges, in Hong Kong, China July 19, 2022. REUTERS/Lam Yik Register now for FREE unlimited access ...
  • A-Mark Precious Metals (NASDAQ:AMRK) vs. Maison Luxe (OTCMKTS:MASN) Head-To-Head Comparison

    By Megan
    August 10, 2022
  • Stock Market LIVE: Indices flat; Nifty below 17,500; IT, Media drag

    By Megan
    August 10, 2022
  • The big change coming to Australian inflation after Reserve Bank governor Philip Lowe laughed at

    By Megan
    August 10, 2022
  • South Korean won, Philippines peso lead losses among subdued Asian currencies

    By Megan
    August 10, 2022
  • Recent

  • Popular

  • Comments

  • Asian shares fall as investors brace for inflation report

    By Megan
    August 10, 2022
  • A-Mark Precious Metals (NASDAQ:AMRK) vs. Maison Luxe (OTCMKTS:MASN) Head-To-Head Comparison

    By Megan
    August 10, 2022
  • Stock Market LIVE: Indices flat; Nifty below 17,500; IT, Media drag

    By Megan
    August 10, 2022
  • The big change coming to Australian inflation after Reserve Bank governor Philip Lowe laughed at

    By Megan
    August 10, 2022
  • Asian shares fall as investors brace for inflation report

    By Megan
    August 10, 2022
  • Australian economy survived Covid better than most but recovery could slow, OECD says | Australian ...

    By Megan
    September 14, 2021
  • The Best Online Brokers, According to 5 Financial Experts

    By Megan
    September 14, 2021
  • Is Disaster Looming for Australia’s Economy?

    By Megan
    September 29, 2021

Trending News

  • Stock Shares

    Asian shares fall as investors brace for inflation report

    People walk past a screen displaying the Hang Seng stock index outside Hong Kong Exchanges, in Hong Kong, China July 19, 2022. REUTERS/Lam Yik Register now for FREE unlimited access ...
  • Gold and Precious Metals

    A-Mark Precious Metals (NASDAQ:AMRK) vs. Maison Luxe (OTCMKTS:MASN) Head-To-Head Comparison

    A-Mark Precious Metals (NASDAQ:AMRK – Get Rating) and Maison Luxe (OTCMKTS:MASN – Get Rating) are both small-cap consumer discretionary companies, but which is the superior business? We will compare the ...
  • Stock Shares

    Stock Market LIVE: Indices flat; Nifty below 17,500; IT, Media drag

    Asian markets started on a negative note following a retreat in Wall Street. This was mostly due to the caution ahead of US inflation data that will shape nvestor expectations ...
  • Australian Economy

    The big change coming to Australian inflation after Reserve Bank governor Philip Lowe laughed at

    How Reserve Bank boss getting LAUGHED at on the world stage will radically change Australia’s economy The Australian Bureau of Statistics is trialing a new monthly inflation data series Reserve ...
  • Currencies

    South Korean won, Philippines peso lead losses among subdued Asian currencies

    BENGALURU (Aug 10): Most Asian currencies were subdued on Wednesday, while most stock markets in the region fell, tracking losses on Wall Street, as investors awaited US inflation data later ...
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
© Copyright The Oceania Times. All rights reserved.

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.